Get started
Author

Adeniyi Olagunju

Observed names: A Olagunju, Adeniyi Ebenezer Olagunju, Olagunju, Adeniyi
Observed institutions: Ekiti State University, University of Ilorin, University of Liverpool, Adekunle Ajasin University, University of Belgrade, Centre of Excellence for Long-acting Therapeutics, Obafemi Awolowo University
ORCID: 0000-0002-6588-5749
Observed ORCID: 0000-0002-6588-5749
OpenAlex ID: A5037090118
Optimizing Pharmacology Studies in Pregnant and Lactating Women Using Lessons From HIV: A Consensus Statement
2020 · Ahizechukwu C. Eke, Adeniyi Olagunju, et al. · Clinical Pharmacology & Therapeutics · 51
PDF
Plasma and breast milk pharmacokinetics of emtricitabine, tenofovir and lamivudine using dried blood and breast milk spots in nursing African mother–infant pairs
2017 · Catriona Waitt, Adeniyi Olagunju, et al. · Journal of Antimicrobial Chemotherapy · 49
PDF
Pharmacogenetics of pregnancy‐induced changes in efavirenz pharmacokinetics
2015 · A Olagunju, O Bolaji, et al. · Clinical Pharmacology & Therapeutics · 48
Development, validation and clinical application of a novel method for the quantification of efavirenz in dried breast milk spots using LC-MS/MS
2014 · Adeniyi Olagunju, Oluseye O. Bolaji, et al. · Journal of Antimicrobial Chemotherapy · 40
PDF
Breast Milk Pharmacokinetics of Efavirenz and Breastfed Infants' Exposure in Genetically Defined Subgroups of Mother-Infant Pairs: An Observational Study
2015 · Adeniyi Olagunju, Oluseye Bolaji, et al. · Clinical Infectious Diseases · 39
PDF
The impact of genetic polymorphisms on the pharmacokinetics of efavirenz in African children
2016 · Andrzej Bienczak, Adrian Cook, et al. · British Journal of Clinical Pharmacology · 37
PDF
Development, validation and clinical application of a method for the simultaneous quantification of lamivudine, emtricitabine and tenofovir in dried blood and dried breast milk spots using LC–MS/MS
2017 · Catriona Waitt, Sujan Diliiy Penchala, et al. · Journal of Chromatography B · 34
PDF
Use of a physiologically-based pharmacokinetic model to simulate artemether dose adjustment for overcoming the drug-drug interaction with efavirenz
2013 · Marco Siccardi, Adeniyi Olagunju, et al. · In Silico Pharmacology · 32
PDF
A Validated Method for Quantification of Efavirenz in Dried Blood Spots Using High-Performance Liquid Chromatography–Mass Spectrometry
2014 · Alieu B. Amara, Laura J. Else, et al. · Therapeutic Drug Monitoring · 31
The Effect of Gene Variants on Levonorgestrel Pharmacokinetics When Combined With Antiretroviral Therapy Containing Efavirenz or Nevirapine
2017 · M Neary, M Lamorde, et al. · Clinical Pharmacology & Therapeutics · 30
Innovative Approaches for Pharmacology Studies in Pregnant and Lactating Women: A Viewpoint and Lessons from HIV
2020 · Ahizechukwu C. Eke, Adeniyi Olagunju, et al. · Clinical Pharmacokinetics · 29
PDF
Using mechanistic physiologically-based pharmacokinetic models to assess prenatal drug exposure: Thalidomide versus efavirenz as case studies
2019 · Shakir Adeyinka Atoyebi, Rajith K.R. Rajoli, et al. · European Journal of Pharmaceutical Sciences · 29
PDF
A Population Pharmacokinetic Analysis Shows that Arylacetamide Deacetylase (AADAC) Gene Polymorphism and HIV Infection Affect the Exposure of Rifapentine
2019 · Jose Francis, Simbarashe P. Zvada, et al. · Antimicrobial Agents and Chemotherapy · 27
PDF
Potential Effect of Pharmacogenetics on Maternal, Fetal and Infant Antiretroviral Drug Exposure During Pregnancy and Breastfeeding
2012 · Adeniyi Olagunju, Andrew Owen, et al. · Pharmacogenomics · 27
Physiologically‐based pharmacokinetic modelling of long‐acting injectable cabotegravir and rilpivirine in pregnancy
2024 · Shakir Atoyebi, Fazila Bunglawala, et al. · British Journal of Clinical Pharmacology · 26
PDF
CYP3A4*22 (c.522-191 C>T; rs35599367) is associated with lopinavir pharmacokinetics in HIV-positive adults
2014 · Adeniyi Olagunju, Alessandro Schipani, et al. · Pharmacogenetics and Genomics · 26
Validation and clinical application of a method to quantify nevirapine in dried blood spots and dried breast-milk spots
2015 · Adeniyi Olagunju, Alieu Amara, et al. · Journal of Antimicrobial Chemotherapy · 24
PDF
Physiologically-based pharmacokinetic modelling of infant exposure to efavirenz through breastfeeding
2018 · Adeniyi Olagunju, Rajith K. R. Rajoli, et al. · AAS Open Research · 18
Effect of Pregnancy on the Pharmacokinetic Interaction between Efavirenz and Lumefantrine in HIV-Malaria Coinfection
2018 · Adebanjo Adegbola, Rana Abutaima, et al. · Antimicrobial Agents and Chemotherapy · 15
PDF
CYP2B6 516G>T (rs3745274) and Smoking Status Are Associated With Efavirenz Plasma Concentration in a Serbian Cohort of HIV Patients
2014 · Adeniyi Olagunju, Marco Siccardi, et al. · Therapeutic Drug Monitoring · 14
Pregnancy affects nevirapine pharmacokinetics
2016 · Adeniyi Olagunju, Oluseye Bolaji, et al. · Pharmacogenetics and Genomics · 13
Mechanistic Modeling of Maternal Lymphoid and Fetal Plasma Antiretroviral Exposure During the Third Trimester
2021 · Babajide Shenkoya, Shakir Atoyebi, et al. · Frontiers in Pediatrics · 12
Class-specific relative genetic contribution for key antiretroviral drugs
2015 · Marco Siccardi, Adeniyi Olagunju, et al. · Journal of Antimicrobial Chemotherapy · 12
PDF
Associations between efavirenz concentrations, pharmacogenetics and neurocognitive performance in people living with HIV in Nigeria
2021 · Jacinta N. Nwogu, Monica Gandhi, et al. · AIDS · 11
Quality of artemisinin-based antimalarial drugs marketed in Nigeria
2017 · Oisaemi Izevbekhai, Babatunde Adeagbo, et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene · 11
Works count: 83
Citation count: 842
H-index: 18
I10-index: 26
Year
Topic
Type